found that metformin treatment in PCOS may decrease NOX2 levels by upregulating miR-670-3p, thereby reducing ROS production, inhibiting NLRP3 inflammasome activation, and improving KGN cell pyroptosis (31). This evidence concerns the gene NLRP3 and polycystic ovary syndrome.